294. Congenital diaphragmatic hernia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 16 / Drugs : 26 - (DrugBank : 5) / Drug target genes : 5 - Drug target pathways : 14
Congenital diaphragmatic hernia and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 294 | Congenital diaphragmatic hernia | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 5.000 |
| 6 | Parkinson disease | 5.000 |
| 21 | Mitochondrial disease | 5.000 |
| 299 | Cystic fibrosis | 5.000 |
| 2 | Amyotrophic lateral sclerosis | 5.000 |
| 46 | Malignant rheumatoid arthritis | 5.000 |
| 51 | Scleroderma | 5.000 |
| 96 | Crohn disease | 5.000 |
| 97 | Ulcerative colitis | 5.000 |
| 63 | Idiopathic thrombocytopenic purpura | 3.271 |
| 282 | Congenital dyserythropoietic anemia | 2.000 |
| 265 | Lipodystrophy | 1.938 |
| 225 | Congenital nephrogenic diabetes insipidus | 1.920 |
| 78 | Hypopituitarism | 1.882 |
| 113 | Muscular dystrophy | 1.861 |
| 226 | Interstitial cystitis with Hunners ulcer | 1.856 |
| 85 | Idiopathic interstitial pneumonia | 1.836 |
| 86 | Pulmonary arterial hypertension | 1.836 |
| 71 | Idiopathic osteonecrosis of the femoral head | 1.400 |
| 166 | Pseudoxanthoma elasticum | 1.280 |
| 124 | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy | 1.200 |